This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Prediction of Response to Anti-PD-1 Therapy in Patients With Non-small-cell Lung Cancer by Electronic Nose Analysis of Exhaled Breath

Friday, September 20, 2019

Submitted by


R de Vries, M Muller, V van der Noort, W S M E Theelen, R D Schouten, K Hummelink, S H Muller, M Wolf-Lansdorf, J W F Dagelet, K Monkhorst, A H Maitland-van der Zee, P Baas, P J Sterk, M M van den Heuvel

Immune checkpoint inhibitors have revolutionized treatment of non-small cell lung cancer. In this study, breath prophiles were collected from 143 patients and a single biomarker profile was created that detected responses to anti-PD-1 treatment with 89% accuracy.

Add comment

Log in or register to post comments